Parallel Advisors’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Parallel Advisors’s Portfolio BDSI Stock Details BDSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-89	Closed	–	–	3453
2021 Q4	$0	Buy	+89	New	+$300	﹤0.01%	3460

Other funds holding BDSI

CAM

Close Asset Management London, United Kingdom $3.69B AUM 21.62% 1-Year Est. Return

FCMT

Founders Capital Management (Texas) Houston, Texas $231M AUM 61.68% 1-Year Est. Return

Parallel Advisors's BDSI Position: Q1 2022 in Review

Parallel Advisors sold out of BioDelivery Sciences International, Inc. (BDSI) in Q1 2022, closing a stake of 89 shares.

Parallel Advisors first reported a position in BDSI in Q4 2021 and held it in 1 quarter. The position peaked at $0 in Q4 2021. 2 funds tracked by Wall St. Rank hold BDSI as of Q1 2022.

Parallel Advisors reported no remaining BioDelivery Sciences International, Inc. position as of Q1 2022 after selling out during the quarter.
Parallel Advisors sold 89 BioDelivery Sciences International, Inc. shares in Q1 2022.
Parallel Advisors first reported a position in BioDelivery Sciences International, Inc. in Q4 2021 and held it in 1 quarter.
Parallel Advisors's BioDelivery Sciences International, Inc. position peaked at $0 in Q4 2021.
2 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q1 2022.

Based on Parallel Advisors's 13F filing for Q1 2022, filed 28 Apr 2022.